The effects of irreversible electroporation (IRE) on nerves

Wei Li, Qingyu Fan, Zhenwei Ji, Xiuchun Qiu, Zhao Li, Wei Li, Qingyu Fan, Zhenwei Ji, Xiuchun Qiu, Zhao Li

Abstract

Background: If a critical nerve is circumferentially involved with tumor, radical surgery intended to cure the cancer must sacrifice the nerve. Loss of critical nerves may lead to serious consequences. In spite of the impressive technical advancements in nerve reconstruction, complete recovery and normalization of nerve function is difficult to achieve. Though irreversible electroporation (IRE) might be a promising choice to treat tumors near or involved critical nerve, the pathophysiology of the nerve after IRE treatment has not be clearly defined.

Methods: We applied IRE directly to a rat sciatic nerve to study the long term effects of IRE on the nerve. A sequence of 10 square pulses of 3800 V/cm, each 100 µs long was applied directly to rat sciatic nerves. In each animal of group I (IRE) the procedure was applied to produce a treated length of about 10 mm. In each animal of group II (Control) the electrodes were only applied directly on the sciatic nerve for the same time. Electrophysiological, histological, and functional studies were performed on immediately after and 3 days, 1 week, 3, 5, 7 and 10 weeks following surgery.

Findings: Electrophysiological, histological, and functional results show the nerve treated with IRE can attain full recovery after 7 weeks.

Conclusion: This finding is indicative of the preservation of nerve involving malignant tumors with respect to the application of IRE pulses to ablate tumors completely. In summary, IRE may be a promising treatment tool for any tumor involving nerves.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Functional recovery after sciatic nerve…
Figure 1. Functional recovery after sciatic nerve injury.
(a) Measurements made from walking track prints were then submitted to SFI. (b) NCV evaluation before and immediately after sciatic nerve injury. (c) NCV evaluation at 3 days, 1 week, 3, 5, 7, and 10 weeks after sciatic nerve injury. (d) CMAP evaluation before and immediately after sciatic nerve injury. (e) CMAP evaluation at 3 days, 1 week, 3, 5, 7, and 10 weeks after sciatic nerve injury. *P<0.05, **P<0.01 versus control group.
Figure 2. Remyelination of sciatic nerves.
Figure 2. Remyelination of sciatic nerves.
(a–c, g–i) Toluidine blue staining. Light micrographs of transverse semi-thin sections at the injury sites of IRE at 3 days, 1 week, 3, 5, 7 and 10 weeks after injury. (d–f, j–l) Transmission electron micrographs(TEMs). Ultra-thin sections at the injury sites of IRE at 3 days, 1 week, 3, 5, 7 and 10 weeks after injury were observed under TEM. Scale bars: A–C, G–I, 10 µm. D–F, J–L, 1 µm.
Figure 3
Figure 3
(a) The statistical analysis of the number of myelinated axons. (b) The statistical analysis of thickness of myelin sheath.
Figure 4. Histological analysis of target muscle.
Figure 4. Histological analysis of target muscle.
(a–f) Hematoxylin and eosin staining. Light micrographs of transverse sectioned gastrocnemius muscle on the IRE side at 3 days, 1 week, 3, 5, 7 and 10 weeks after injury. Scale bars: 10 µm.
Figure 5. The statistical analysis of the…
Figure 5. The statistical analysis of the average percentage muscle fiber area.
There were no significant differences between IRE and the control.
Figure 6. The IRE device clamping the…
Figure 6. The IRE device clamping the exposed right sciatic nerve.

References

    1. Ferguson PC, Kulidjian AA, Jones KB, Deheshi BM, Wunder JS. Peripheral nerve considerations in the management of extremity soft tissue sarcomas. Recent Results Cancer Res. 2009;179:243–256.
    1. Terzis JK, Konofaos P. Nerve transfers in facial palsy. Facial plastic surgery: FPS. 2008;24:177–193.
    1. Tsuchihara T, Nemoto K, Arino H, Amako M, Murakami H, et al. Sural nerve grafting for long defects of the femoral nerve after resection of a retroperitoneal tumour. J Bone Joint Surg Br. 2008;90:1097–1100.
    1. Gordon T, Sulaiman OA, Ladak A. Chapter 24: Electrical stimulation for improving nerve regeneration: where do we stand? Int Rev Neurobiol. 2009;87:433–444.
    1. Lundborg G. Enhancing posttraumatic nerve regeneration. J Peripher Nerv Syst. 2002;7:139–140.
    1. Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, et al. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer research. 2010;70:1555–1563.
    1. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Journal of vascular and interventional radiology: JVIR. 2009;20:S377–390.
    1. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat. 2007;6:37–48.
    1. Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6:307–312.
    1. Lee EW, Thai S, Kee ST. Irreversible Electroporation: A Novel Image-Guided Cancer Therapy. Gut Liver. 2010;4:S99–S104.
    1. Thomson K. Rubinsky B, editor. Human Experience with Irreversible Electroporation. Irreversible Electroporation: Springer Berlin Heidelberg. 2010. pp. 249–254.
    1. Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg. 2010;110:1305–1309.
    1. Pech M, Janitzky A, Wendler JJ, Strang C, Blaschke S, et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovascular and interventional radiology. 2011;34:132–138.
    1. Onik G, Mikus P, Rubinsky B. Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat. 2007;6:295–300.
    1. Abramov GS, Bier M, Capelli-Schellpfeffer M, Lee RC. Alteration in sensory nerve function following electrical shock. Burns: journal of the International Society for Burn Injuries. 1996;22:602–606.
    1. Onik G, Rubinsky B. Rubinsky B, editor. Irreversible Electroporation: First Patient Experience Focal Therapy of Prostate Cancer. Irreversible Electroporation: Springer Berlin Heidelberg. 2010. pp. 235–247.
    1. Rafiuddin Ahmed M, Jayakumar R. Peripheral nerve regeneration in RGD peptide incorporated collagen tubes. Brain research. 2003;993:208–216.
    1. Fernandes M, Valente SG, Fernandes MJ, Felix EP, Mazzacoratti Mda G, et al. Bone marrow cells are able to increase vessels number during repair of sciatic nerve lesion. Journal of Neuroscience Methods. 2008;170:16–24.
    1. Burnett MG, Zager EL. Pathophysiology of peripheral nerve injury: a brief review. Neurosurg Focus. 2004;16:E1.
    1. Fu SY, Gordon T. The cellular and molecular basis of peripheral nerve regeneration. Mol Neurobiol. 1997;14:67–116.
    1. Rubinsky B. Irreversible electroporation in medicine. Technol Cancer Res Treat. 2007;6:255–260.
    1. Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005;33:223–231.
    1. Shafiee H, Garcia PA, Davalos RV. A preliminary study to delineate irreversible electroporation from thermal damage using the arrhenius equation. J Biomech Eng. 2009;131:074509.
    1. Choi YS, Kim HB, Chung J, Kim HS, Yi JH, et al. Preclinical analysis of irreversible electroporation on rat liver tissues using a microfabricated electroporator. Tissue Eng Part C Methods. 2010;16:1245–1253.
    1. Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, et al. Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology. 2010;255:426–433.
    1. Tekle E, Wolfe MD, Oubrahim H, Chock PB. Phagocytic clearance of electric field induced 'apoptosis-mimetic' cells. Biochemical and biophysical research communications. 2008;376:256–260.
    1. Maor E, Ivorra A, Rubinsky B. Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS One. 2009;4:e4757.
    1. Griffin JW, Pan B, Polley MA, Hoffman PN, Farah MH Measuring nerve regeneration in the mouse. Exp Neurol. 223:60–71.
    1. Fullarton AC, Lenihan DV, Myles LM, Glasby MA. Obstetric brachial plexus palsy: a large animal model for traction injury and its repair. Part 1: age of the recipient. J Hand Surg Br. 2000;25:52–57.
    1. Hess JR, Brenner MJ, Fox IK, Nichols CM, Myckatyn TM, et al. Use of cold-preserved allografts seeded with autologous Schwann cells in the treatment of a long-gap peripheral nerve injury. Plast Reconstr Surg. 2007;119:246–259.
    1. Bain JR, Mackinnon SE, Hunter DA. Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg. 1989;83:129–138.
    1. Hare GM, Evans PJ, Mackinnon SE, Best TJ, Bain JR, et al. Walking track analysis: a long-term assessment of peripheral nerve recovery. Plast Reconstr Surg. 1992;89:251–258.
    1. George LT, Myckatyn TM, Jensen JN, Hunter DA, Mackinnon SE. Functional recovery and histomorphometric assessment following tibial nerve injury in the mouse. J Reconstr Microsurg. 2003;19:41–48.
    1. Suzuki Y, Tanihara M, Ohnishi K, Suzuki K, Endo K, et al. Cat peripheral nerve regeneration across 50 mm gap repaired with a novel nerve guide composed of freeze-dried alginate gel. Neurosci Lett. 1999;259:75–78.

Source: PubMed

3
Subscribe